Navigation Links
Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn
Date:4/29/2009

Company's work could help farmers protect against billions in pest losses annually

St. Louis, MO (PRWEB) April 29, 2009 -- In the past year, St. Louis biotech firm Divergence, Inc., has received more than $1.2 million in research grants, including a $500,000 grant just awarded from the National Science Foundation (NSF) to further the company's work on biotech traits for lesion nematode control in crops such as corn. The Phase II grant, "Control of Lesion Nematodes by RNA Interference," is part of NSF's Small Business Innovation Research (SBIR) program.

Nematodes are the largest unsolved pest problem in agriculture, limiting the yield of crops worldwide and causing billions of dollars in crop damage annually. Lesion nematodes are prevalent in the Corn Belt and appear to be increasing with changing agronomic practices. Divergence, a world leader in developing products for control of parasites in agriculture and medicine, has discovered nematicidal chemistry working through a novel mode of action and is also working on biotechnology-derived crops with built-in pest resistance.

The company's Phase I research demonstrated that RNA interference (RNAi) can substantially reduce lesion nematode reproduction resulting in a larger, healthier root system for a plant. The Phase II grant will allow Divergence to expand greenhouse testing in crops including corn. RNAi is a fundamental mechanism of gene regulation triggered by double-stranded RNA. Divergence was an early industrial adopter of RNAi, working with the research platform since the company's inception in 1999. Dr. Craig Mello, a member of Divergence's Scientific Advisory Board since 2000, was the co-recipient of the 2006 Nobel Prize in Physiology or Medicine for the discovery of RNAi.

"Our proje
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Divergence Raises $11.8 Million in Series C Financing
2. OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
3. China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India
4. China Medical Technologies Receives SFDA Approval for Its Bladder Cancer FISH Probe
5. Mach One BioPharm Process Operating Group Receives Contract From American Beef Processors
6. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
7. Sunesis Pharmaceuticals Receives NASDAQ Notification
8. XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel
9. Cambrex Receives Notice Regarding NYSE Listing
10. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
11. Vertebral Technologies Receives Award for InterFuse(R) Interbody Fusion System
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn
(Date:7/10/2014)... 10, 2014 Understanding the need for ... lines, and the gap that currently exists in this ... its industry-leading portfolio of validated ion channel and GPCR ... cell lines, as ion channels control many critical physiological ... activity creates the potential to treat a variety of ...
(Date:7/10/2014)... Unraveling life’s mysteries can intrigue, amaze, and ... purchased a DNA test to unravel the ... a lifetime of memories, sharing, and closeness. In fact, ... genuinely brought the family closer together. , Recently, ... history and prior to taking the genetic ancestry ...
(Date:7/10/2014)... July 10, 2014 OMICS Group’s 5th ... during 18-20 August, 2014 at Double Tree by Hilton ... recent developments in Analytical & Bioanalytical research methods only ... Speaking on this occasion, Dr. Srinubabu Gedela, MD of ... conference is a remarkable one in bringing a unique ...
(Date:7/10/2014)... Senior supply chain management executives from over ... challenges of “Reducing Cost, Lead Time, & Defects in ... Describing the partnership of the Bio Supply Management Alliance ... ( SCMI) of the University of San Diego ... Kroc Institute of Peace and Justice in San Diego, ...
Breaking Biology Technology:Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4
... particle (VLP) vaccine progresses with study designed to select ... Novavax, Inc. (Nasdaq: NVAX ) announced ... trial of its virus-like particle (VLP) seasonal influenza vaccine. ... II randomized, placebo controlled clinical trial has been designed ...
... France, May 5 Novagali Pharma, a ... Company,s,Investigational New Drug Application (IND) to conduct ... for the treatment of glaucoma has been,granted ... (FDA). Catioprost(R) is a,topical ocular proprietary BAK-free ...
... FRANCISCO, Calif., May 5 Poniard Pharmaceuticals, Inc. (Nasdaq: ... Data Monitoring Committee (DMC), after review of available information ... recommends that the SPEAR (Study of Picoplatin Efficacy After ... is evaluating the efficacy and safety of picoplatin in ...
Cached Biology Technology:Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 2Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 3Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate 4Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 2Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 2Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 3Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 4Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer 5
(Date:7/11/2014)... that let nerve cells send out electrical signals, Johns ... tactic that may offer a new way to protect ... responsible way. , Their findingthat naturally occurring insect ... for a closely related onesuggests that insecticides can be ... like bees. A summary of the research, led by ...
(Date:7/10/2014)... Colo. , June 27, 2014  The ... the National Institute of Standards and Technology (NIST) ... of its academic research and forensic science expert ... The Board is an element of the NIST,s ... members are among the first appointments made to ...
(Date:7/10/2014)... SPRINGS, Florida , July 1, 2014 ... wallets pave way for convenience and improved security: NXT-ID, Inc. ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ... and MasterCard Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: NXTD) ... is pleased to announce that the second series of 30 ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5
... 2009A research team including Serge Rivest of University Laval,s Faculty ... cells that limits brain damage after a stroke. The study ... Medicine . Laboratory experiments showed that three days after ... larger in mice without regulatory T (Treg) cells than in ...
... 2009 A new study by researchers at Princeton ... has found that global climate change may lead to ... western United States, which could create unprecedented ecological restoration ... the same time, global warming may enable other invasive ...
... 2009 Designed to inspire innovative ideas for environmentally-friendly ... Smart Gear Competition with a call for new designs ... species in fishing gear. The competition is open to ... $57,500 in prizes. "Bycatch is one of the ...
Cached Biology News:Researchers identify a cell type that limits stroke damage 2Climate change's impact on invasive plants in Western US may create restoration opportunities 2Climate change's impact on invasive plants in Western US may create restoration opportunities 3Climate change's impact on invasive plants in Western US may create restoration opportunities 4WWF seeks innovative solutions to bycatch through worldwide competition 2
Polyclonal Antibody to Coronin / CORO1C This antibody was developed against synthetic peptides corresponding to amino acids 407-420 of human CORO1C....
Mouse Wnt-9b Biotinylated Affinity Purified PAb ENTREZ GeneID: 22412...
Homo sapiens MEP50 protein, mRNA...
... co-precipitant, 250 ul (125 ... ensures easy pellet location.Efficient ... recovery.Chemically inert, compatible with ... 5-minute protocol. Category: DNA/RNA ...
Biology Products: